The major inflammatory mediator interleukin-6 and obesity.
about
Stimulation of incretin secreting cellsThe "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammationAdipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesTumor necrosis factor- α and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndromeMitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibilityThe effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissueThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityThe tumor microenvironment in esophageal cancerA high cholesterol diet elevates hippocampal cytokine expression in an age and estrogen-dependent manner in female ratsAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesityInterleukin-6 gene polymorphisms, dietary fat intake, obesity and serum lipid concentrations in black and white South African women.A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance.Regional adipose tissue hormone/cytokine production before and after weight loss in abdominally obese women.Interleukin-6 in bone metastasis and cancer progression.Dietary energy balance modulates ovarian cancer progression and metastasis.Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat.Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance.Dietary, anthropometric, and biochemical determinants of plasma high-density lipoprotein-cholesterol in free-living adultsMetabolic and inflammatory genes in schizophrenia.Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular riskInflammatory response to fine particulate air pollution exposure: neutrophil versus monocyte.The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: effect of exercise.The gp130 receptor cytokine family: regulators of adipocyte development and function.Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells.Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice.Non-alcoholic fatty liver disease and psoriasis: So far, so near.Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents.Arteriolar function in visceral adipose tissue is impaired in human obesityObesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic InflammationAdipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 productionBenefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults.Impact of the -174 G > C IL-6 polymorphism on bioelectrical parameters in obese subjects after laparoscopic adjustable gastric banding.Systemic inflammatory load in young and old ringdoves is modulated by consumption of a Jerte Valley cherry-based product.Interleukins 6 and 15 Levels Are Higher in Subcutaneous Adipose Tissue, but Obesity Is Associated with Their Increased Content in Visceral Fat DepotsSystemic inflammation and insulin sensitivity in obese IFN-γ knockout miceSympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity.Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension
P2860
Q26765259-2E4ACB8F-42E6-4EE7-BB76-A825E625AEF5Q26798273-6A1B6A65-1D3F-4C58-92EE-199FD7A6BC47Q27001148-9A56EF12-2AAD-4E81-B158-B954CFF3D035Q27021308-666AC899-ABFA-4071-BD52-1A1D4D2C9F65Q27022800-49007FC5-E41C-4CB6-9ADB-39BAD4E196F5Q27024390-B8400520-6BA0-4BCB-A164-E51EB2B323D7Q28067835-31E79A46-4902-4BE8-9C47-30641594FB02Q28077074-9EC18533-EC63-4751-B55D-D23FCB0B8D05Q28583916-04820FE3-DBC4-43DE-A6DE-73F1F4ADDAB7Q33692555-77824DED-EAB5-472E-AB92-BC0D4F549BDFQ33711482-1267390D-4081-42A7-AFB3-950879F89127Q33813783-A7FC42B6-4F2F-4AD5-AC90-12012D79385CQ33816671-60651E8F-77FE-42A7-9F26-4B99342194EAQ33831518-DB31F0F4-DFF8-45C9-B096-6C8E4E5B866FQ34051820-4980ABFD-B624-4C62-B2C8-98F1140546B0Q34227594-98704B56-CD6C-4493-95D2-9B0A3DE275B2Q34426831-9BC6379A-F7A5-4F3F-A92D-853509BD58E5Q34623190-39D889E3-3B67-4352-90C4-630B5D61BFC4Q34723169-CD5B8489-1339-4FD6-91D0-D514F5E5221CQ34730568-CBA7F2FD-7462-495D-861A-2C31B79C41B4Q34769260-FEBDAFAA-A1AB-425B-B94E-ABE17A86CAA3Q34893465-38B3832C-8764-4821-9492-8CF2317DA6B1Q34949504-3A3372A0-F369-49B4-9643-91F719607A12Q35054609-0C8E2D8D-F243-4BC5-B525-A7C035432828Q35059389-65E355F2-54BB-46A9-AA93-955A26757B5FQ35175008-C0226D3F-B9AC-401B-9593-5DF134C76E22Q35181392-71E74310-3A32-42B3-BEA4-793151E90524Q35227727-391E3B83-2D27-4E71-8388-536AECE7FE52Q35237307-24093632-9DDA-4325-9048-B66D146A65F5Q35589813-F5F9ABAD-95D5-4E39-9C85-109867958225Q35683298-C7BB8EE6-2AA5-4495-B145-CAF901B62ED2Q35705451-74252192-E8E1-4688-B8C4-305904C60F67Q35781395-DB508D44-28B2-4F9D-B8EE-3606E612C505Q35810477-7E48BD9A-673E-4CFA-9CD8-C91602CD6F96Q35994174-B0E69618-48F9-4A02-9E32-E2CBEAC740CBQ36124295-F1CE6680-1525-45A1-9E7C-0AE166FD6342Q36247603-98535C1C-1669-4858-97A2-0412327998A8Q36278695-C49E2825-320E-4E1B-A992-0B964BF8198AQ36422587-832DECA2-32DE-4452-9282-A62ADFCBEA32Q36577011-1B98D359-86CE-4611-B8D4-911AD1344FF5
P2860
The major inflammatory mediator interleukin-6 and obesity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The major inflammatory mediator interleukin-6 and obesity.
@en
The major inflammatory mediator interleukin-6 and obesity.
@nl
type
label
The major inflammatory mediator interleukin-6 and obesity.
@en
The major inflammatory mediator interleukin-6 and obesity.
@nl
prefLabel
The major inflammatory mediator interleukin-6 and obesity.
@en
The major inflammatory mediator interleukin-6 and obesity.
@nl
P2093
P2860
P921
P1476
The major inflammatory mediator interleukin-6 and obesity.
@en
P2093
Andras Falus
Andras K Fulop
Katalin Eder
Noemi Baffy
P2860
P2888
P304
P356
10.1007/S00011-009-0060-4
P577
2009-06-19T00:00:00Z